Compugen Ltd.
CGEN
$2.24
$0.031.36%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/12/2026
-
Insider Monkey
3/9/2026
-
Insider Monkey
3/3/2026
-
Insider Monkey
3/3/2026
-
TipRanks Financial Blog
3/2/2026
-
Simply Wall St
3/2/2026
-
SeekingAlpha
3/2/2026
-
Seeking Alpha - Long Ideas
3/2/2026
-
Seeking Alpha - Israel Stocks
3/2/2026
-
Seeking Alpha - Healthcare
3/2/2026
-
Seeking Alpha: Transcripts
3/2/2026
-
Seeking Alpha - Israel Stocks
3/2/2026
-
SeekingAlpha
3/2/2026
-
Fool.com Headlines
3/2/2026
-
Zacks Investment Research
3/2/2026
-
The Fly
3/2/2026
-
Seeking Alpha - Israel Stocks
3/2/2026
-
Benzinga
3/2/2026
-
PR Newswire
2/27/2026
-
Benzinga
2/26/2026
-
Zacks Investment Research
2/26/2026
-
Zacks Investment Research
2/19/2026
-
Zacks Investment Research
2/19/2026
-
PR Newswire
2/17/2026
-
PR Newswire
2/12/2026
-
PR Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, March 2, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 18 and 22 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 3 765 8585
Address
Azrieli Center
Building D - 26 Harokmim Street
Holon, 5885849
Building D - 26 Harokmim Street
Holon, 5885849
Country
Year Founded
Business Description
Sector
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the...
more